Please login to the form below

Not currently logged in
Email:
Password:

Biogen’s corporate affairs SVP joins Sanofi

Kathleen Tregoning becomes executive vice president, external affairs

Sanofi Kathleen TregoningSanofi has appointed Kathleen Tregoning as executive vice president for external affairs.

Tregoning will join the Paris, France headquartered company from 27 February, when she will take responsibility for its market access, public affairs, government affairs, corporate communications, global policy and corporate social responsibility operations.

She brings over 20 years of policy, advocacy, stakeholder outreach and external engagement experience to the role, most recently from Biogen where she was senior vice president of corporate affairs.

Prior to this, Tregoning was vice president of Biogen's public policy and government affairs, having moved to the biotech in 2006 from her healthcare policy position in the United States Senate and United States House of Representatives.

Olivier Brandicourt, chief executive at Sanofi, said: “Kathleen brings a unique set of talents and experience to Sanofi that combines a deep political and policy expertise with highly relevant corporate experience in the biopharmaceutical industry.

"Working closely with the entire executive leadership team, Kathleen will lead our efforts to drive a better understanding of the value of our innovations among external stakeholders and ensure appropriate market access for our various healthcare offerings.”

30th January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics